Lifecore Biomedical market cap LFCR

Share price times shares outstanding: what the whole company sells for, since 2011.

Lifecore Biomedical is worth $242.3M at the close on Oct 23, 2026, at $6.40 a share.

That is down 4% over the last year and down 15% over five years.

Its highest close in our data was $427.6M in Nov 2018.

Market cap over time

Year	End of year	Low	High	Change
2026 so far	$242.3M	$137.2M	$325.6M	−22%
2025	$311M	$195.9M	$311M	+38%
2024	$224.9M	$135.3M	$259.3M	+20%
2023	$187.7M	$50.6M	$319.7M	−2%
2022	$191.8M	$191.8M	$349.1M	−41%
2021	$327M	$255.4M	$374M	+3%
2020	$317.3M	$221.5M	$344.2M	−5%
2019	$334.4M	$271.7M	$378.3M	+3%
2018	$324.9M	$324.9M	$427.6M	−6%
2017	$346.6M	$315M	$405.5M	−8%
2016	$375.9M	$273.7M	$410M	+18%
2015	$319.6M	$317.7M	$396.1M	−16%
2014	$381.5M	$268.7M	$381.5M	+17%
2013	$325.3M	$283.6M	$399.1M	+37%
2012	$237.6M	$142.2M	$294M	+66%
2011	$143M	$133.7M	$162.2M	n/a

Companies in Drug Manufacturers - General nearest Lifecore Biomedical's size, closest first, today.

Company	Market cap
LFCRLifecore Biomedical	$242.3M
NATRNatures Sunshine Products	$213.8M
ARVNArvinas	$477.3M
PBYIPuma Biotechnology	$568.9M
IRWDIronwood Pharmaceuticals	$571.7M
ZVRAZevra Therapeutics	$582.6M
CRMDCorMedix	$611.9M
COLLCollegium Pharmaceutical	$747.5M
LFVNLifevantage	$73.4M
ABUSArbutus Biopharma	$831M
SPROSpero Therapeutics	$64.6M
Peer median	$570.3M